WEBINAR
Break the Mould: How the Breast Cancer Research Foundation is Accelerating Progress
|
|
More than 44,000 women and men in the US die each year from breast cancer. The Breast Cancer Research Foundation is the largest private funder of breast cancer research, supporting investigators in 15 countries to advance the prevention and cure of breast cancer. Learn how medical discovery in breast cancer research is driven forward from the laboratory to the patient bedside as Dr. Silvia Formenti and Dr. Joan Brugge speak with Betsy Battle.
Break the Mould
This webinar is part of 100 Women in Finance’s 20th Anniversary Celebration and the special 20th Anniversary Break the Mould series of events. These programmes highlight the extraordinary accomplishments of personalities beyond the field of finance. In candid conversations, speakers reflect on aspects of leadership, resilience, role models, navigating challenges and taking opportunities throughout their careers. 100WF members and invited guests will learn from these exceptional individuals, from the arts, science, education, sports, activism, who will share their experiences as pioneers, innovators, disrupters, leaders and noteworthy in their respective fields.
|
|
09:00 AM N. America West Coast
12:00 PM N. America East Coast
05:00 PM London - Dublin
06:00 PM CET
|
The program will begin promptly. |
|
Amanda Pullinger
Opening Remarks
100 Women in Finance
Myra Biblowit
Opening Remarks
Breast Cancer Research Foundation
Dr. Joan Brugge
Ludwig Center at Harvard Medical School
Dr. Silvia Formenti
Weill Cornell Medical College / New York-Presbyterian/Weill Cornell Medical Center
Betsy Battle
Moderator
Lone Peak Partners
|
The webinar access link will be emailed to you separately closer to the date of the event. |
|
You may include a non-member guest with your RSVP.
100WF’s policy is that a non-member may attend one 100WF event as a guest to learn more about 100WF and experience a 100WF event. To attend further events, the guest should register as a 100WF member.
Visit your Member Profile RSVPs to confirm your event registration. If you have no-show fees or access fees due, the system cannot register you for an event. You can view and pay for any outstanding fees on your Member Profile. If you have any membership questions, please contact the Membership Committee.
|
|
Amanda Pullinger
Chief Executive Officer, 100 Women in Finance
Ms. Pullinger is the Chief Executive Officer of 100 Women in Finance. She leads a staff team and provides direction to 500 volunteer practitioners globally. The organization, which now has nearly 20,000 registered members in 27 locations, is focused on empowering women in the finance industry and inspiring the next generation of pre-career young women. Ms. Pullinger is a former principal of Aquamarine Capital Management, where she was responsible, over a period of seven years, for managing marketing, investor relations and back office administration for two private investment funds. Ms. Pullinger is Chair and Non Executive Director of the Board of FlyPlymouth, based in Plymouth, UK. She also serves on the Boards of the HALO Trust (USA), the American Friends of The National Portrait Gallery (London) Foundation and as a Director on the Oxford University Alumni Board. She is President of the Brasenose Society, Vice Chair of the Women’s Network Forum and an Advisory Board Member of the Harambe Entrepreneur Alliance (Harambe). Previously, she served as Chairman of the Board of The HALO Trust (www.halotrust.org) and served on the Board of Langone NYU Cancer Institute. She was on the founding Board of 100 Women in Finance, serving as its President for two years. She is a member of the British Academy of Film and Television Arts (BAFTA) and a Fellow of the Royal Society of Arts. Ms. Pullinger graduated from Brasenose College, Oxford University in 1987 with an Honours Degree in Modern History. She earned an MBA from La Salle University, Philadelphia, in 1998, and received the Academic Award for MBA student of the year as well as the Beta Gamma Sigma designation.
Myra Biblowit
President, Breast Cancer Research Foundation
Myra Biblowit is the President of the Breast Cancer Research Foundation, the nation’s highest-rated breast cancer organization, with a mission focused exclusively on funding research around the globe. Ms. Biblowit partnered with her dear friend Evelyn Lauder to found BCRF in 1993. Their goal was to create an organization with a singular focus on funding research as advances were coming quickly. Ms. Biblowit joined BCRF as President in 2001. That year, BCRF raised $10.6 million and committed $8.5 million to fund 50 researchers in the United States. This year, BCRF has awarded $41 million in grants to 275 clinicians and scientists from top universities and medical institutions across 15 countries, making BCRF the largest private funder of breast cancer research in the world. During Ms. Biblowit’s tenure, BCRF funding has enabled many of the most important breakthroughs in breast cancer prevention, diagnosis, treatment, metastasis and survivorship. Ms. Biblowit has been widely recognized for running one the most financially efficient and transparent nonprofits. Prior to joining BCRF, Ms. Biblowit was Vice Dean for External Affairs at NYU Medical Center where she headed Development, Alumni Relations and Public Relations. Previously she was Senior Vice President and led the Capital Campaign at the American Museum of Natural History. Earlier, Ms. Biblowit served as Executive Vice President of the Central Park Conservancy.
Dr. Joan Brugge
Co-Director, Ludwig Center at Harvard Medical School
Dr. Brugge is a member of the BCRF Scientific Advisory Board, and Co-Director of the Ludwig Center at Harvard Medical School. A graduate of Northwestern University, she did graduate work at the Baylor College of Medicine, completing her PhD in 1975, followed by postdoctoral training at the University of Colorado with Dr. Raymond Erikson. Dr. Brugge has held full professorships at the State University of New York, Stony Brook, and the University of Pennsylvania, where she was also named an investigator at the Howard Hughes Medical Institute. From 1992-1997 Dr. Brugge was Scientific Director of the biotechnology company ARIAD. She joined Harvard in 1997 as Professor of Cell Biology, was Chair of Cell Biology from 2004 - 2014, and became Co-Director of the Ludwig Center at Harvard in 2014. Dr. Brugge’s awards include an NIH Merit Award, an American Cancer Society Research Professorship and the Senior Career Recognition Award from the American Society of Cell Biology. She is the recipient of BCRF's 2015 Jill Rose Award for research excellence. She has been elected to the American Academy of Arts and Sciences, the National Academy of Sciences and the Institute of Medicine.
Dr. Silvia Formenti
Chair Department of Radiation Oncology / Radiation Oncologist-in-Chief, Weill Cornell Medical College / New York-Presbyterian/Weill Cornell Medical Center
Dr. Silvia C. Formenti has been a BCRF grantee since 2002. Dr. Formenti is an international expert in the use of radiation therapy for the treatment of cancer, is Chair of the newly established Department of Radiation Oncology at Weill Cornell Medical College and Radiation Oncologist-in-Chief at New York-Presbyterian/Weill Cornell Medical Center. A prolific researcher, she has published over 180 papers recognized by high impact journals like JAMA, Journal of Clinical Oncology, Lancet Oncology, Science etc. During the past twelve years, Dr. Formenti has introduced a paradigm shift in radiation biology, by elucidating the role of ionizing radiation on the immune system, and demonstrating efficacy of combining radiotherapy with immunotherapy in solid tumors. She has translated her preclinical work to clinical trials in metastatic breast cancer, lung cancer and melanoma. She has introduced the concept of recovering an immunological equilibrium in metastatic disease, by converting a metastasis into an in situ, individualized vaccine. In the presence of immune checkpoint blockade (anti-CTLA-4 , anti-PDL-1) the irradiated tumor becomes an immunogenic hub, similar to a vaccine. Once immunized against one site, the host develops an anti-tumor immune response capable to reject the other metastases. In some patients with metastatic disease refractory to standard treatment the combination of local radiation and immune checkpoint blockade has resulted in durable complete remissions, sustained for years after treatment. Her work has opened a new field of application for radiotherapy, whereby localized radiation can be used as an adjuvant to immunotherapy of solid tumors and lymphomas.
Betsy Battle
Chief Investment Officer and Founding Partner, Lone Peak Partners
Ms. Battle brings almost four decades of financial services and investment experience to Lone Peak Partners. Most recently, she was Director of Manager Selection and a member of the Management Committee at Soros Fund Management LLC. Over her eight years there, she not only managed multibillion dollar portfolios of external hedge funds for the Quantum group of funds and George Soros, but also built the manager selection and due diligence processes as well as the multi-manager portfolio construction and monitoring methodologies. Prior to Soros Fund Management, she held positions at Bankers Trust, Citicorp and JP Morgan, primarily as a manager in Global Sales and Trading. She currently serves on the Board of Directors of the University of North Carolina Kenan-Flagler Business School Foundation Board, the Board of Directors of the Breast Cancer Research Foundation, the President’s Council of the Peconic Land Trust, the Carolina Performing Arts International Advisory Board, and is a Fellow at The Frank Hawkins Kenan Institute of Private Enterprise at the University of North Carolina at Chapel Hill. Ms. Battle received a BA from the University of North Carolina at Chapel Hill in 1976. Ms. Battle founded Lone Peak Partners Management LP in July of 2009. The firm registered with the SEC in February 2012. Lone Peak is also registered with the CFTC as a CPO and a CTA and became a member of the NFA in January 2013.
|
|
100WF's 20th Anniversary
Throughout 2021, 100 Women in Finance will celebrate its twentieth year of operations with special events and recognition of the member volunteers who have built 100WF into today’s leading organization dedicated to the advancement of women in the global finance industry. Since its founding in 2001, 100WF’s pillars of Education, Peer Engagement and Impact have established a foundation of purpose, achievement and confidence that will guide the organization's future growth and focus on attaining its 30x40 Vision in the next twenty years.
100 Women in Finance
100 Women in Finance's near 20,000 registered members strengthen the global finance industry by empowering women to achieve their professional potential at each career stage. Its members inspire, equip and advocate for a new generation of industry leadership, in which women and men serve as investment professionals and executives, equal in achievement and impact. Through Education, Peer Engagement and Impact, the organization furthers the progress of women who have chosen finance as a career, and enables their positive influence over pre-career young women.
|
|
This event is NOT FOR ATTRIBUTION. All 100WF events are private events and we require that no one reports publicly on any aspect of them.
100WF Profile Update
Is your profile up to date? If not, we encourage you to update your Member Profile to ensure that you are receiving By Invite Only event invitations and job opportunities, among other targeted and special emails.
100WF Access Fee
Have you paid your access fee? If not please go to 100WF Member Payment. We appreciate your continued support!
|
|
Please do not reply to this email.
If you have any questions about this event, please contact us at the link shown above or visit our website at www.100women.org
You received this email because of your interest in 100 Women in Finance. You can update your email preferences and unsubscribe using the SafeUnsubscribe link below. If you are registered as a 100WF Member or Supporter you can update your registration details, change your email preferences or unsubscribe by logging into your Member Profile.
|
|
|
|
|
|
|
